RecruitingNCT07321899

PATHFINDER

Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation

Medtronic CardiovascularMultiple US sitesView on ClinicalTrials.gov

AI Description

This clinical trial evaluates the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in symptomatic patients with severe or greater tricuspid regurgitation.

Report inaccurate information

Who can join
adult, older adult
Participants
1186
Expected completion
2041-04
Funded by
industry

Conditions studied

Severe Tricuspid Regurgitation

What is being tested

  • DEVICE: Edwards EVOQUE Tricuspid Valve Replacement (TTVR) System
  • DEVICE: Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System

What it measures

  • Composite Endpoint: All-cause mortality, Heart failure hospitalization, and tricuspid valve reintervention, 1-year post-procedure
  • Rate of Major Adverse Events (MAE), 30-days post-procedure

Centers Participating

These centers are participating in this study. Reach out to them directly to learn more.

Abbott Northwestern Hospital

Minneapolis, MN

Los Robles Regional Medical Center

Thousand Oaks, CA

The Christ Hospital

Cincinnati, OH

Data Sources and Methodology

Registry entry updated 2026-07-28

Deciding whether to join a study is your choice, and you can ask a study team questions before you decide anything.

If you would rather we did it with you, call us on (656) 206-4686.

Connect to the HIP teamContact the HIP team for information and support